DE69319920D1 - FO-1289 Verbindung und ihre Herstellung. - Google Patents

FO-1289 Verbindung und ihre Herstellung.

Info

Publication number
DE69319920D1
DE69319920D1 DE69319920T DE69319920T DE69319920D1 DE 69319920 D1 DE69319920 D1 DE 69319920D1 DE 69319920 T DE69319920 T DE 69319920T DE 69319920 T DE69319920 T DE 69319920T DE 69319920 D1 DE69319920 D1 DE 69319920D1
Authority
DE
Germany
Prior art keywords
hydrogen
acetyl
substance
propionyl
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69319920T
Other languages
English (en)
Other versions
DE69319920T2 (de
Inventor
Satoshi Omura
Hiroshi Tomoda
Rokuro Masuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitasato Institute
Original Assignee
Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Institute filed Critical Kitasato Institute
Application granted granted Critical
Publication of DE69319920D1 publication Critical patent/DE69319920D1/de
Publication of DE69319920T2 publication Critical patent/DE69319920T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • C12R2001/66Aspergillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Wire Bonding (AREA)
DE69319920T 1992-10-22 1993-03-26 FO-1289 Verbindung und ihre Herstellung. Expired - Lifetime DE69319920T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28475992 1992-10-22
JP03526193A JP3233476B2 (ja) 1992-10-22 1993-02-24 Fo−1289物質およびその製造法
PCT/JP1993/000367 WO1994009147A1 (en) 1992-10-22 1993-03-26 Fo-1289 substance and its production

Publications (2)

Publication Number Publication Date
DE69319920D1 true DE69319920D1 (de) 1998-08-27
DE69319920T2 DE69319920T2 (de) 1998-12-10

Family

ID=26374213

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69319920T Expired - Lifetime DE69319920T2 (de) 1992-10-22 1993-03-26 FO-1289 Verbindung und ihre Herstellung.

Country Status (15)

Country Link
US (1) US5807721A (de)
EP (1) EP0667914B1 (de)
JP (1) JP3233476B2 (de)
KR (1) KR100323572B1 (de)
AT (1) ATE168722T1 (de)
AU (1) AU664437B2 (de)
CA (1) CA2127878C (de)
DE (1) DE69319920T2 (de)
DK (1) DK0667914T3 (de)
ES (1) ES2119894T3 (de)
FI (1) FI103670B1 (de)
HU (1) HU218015B (de)
NO (1) NO307519B1 (de)
NZ (1) NZ249975A (de)
WO (1) WO1994009147A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI388282B (zh) 2005-06-01 2013-03-11 Meiji Seika Pharma Co Ltd 害蟲控制劑
JP5037164B2 (ja) * 2005-06-01 2012-09-26 Meiji Seikaファルマ株式会社 害虫防除剤
US7491738B2 (en) 2005-06-01 2009-02-17 Meiji Seika Kaisha, Ltd. Pest control agents
KR101486094B1 (ko) * 2007-03-08 2015-01-28 메이지 세이카 파루마 가부시키가이샤 유해생물 방제용 조성물
CN101821272B (zh) * 2007-08-13 2013-03-27 明治制果药业株式会社 生产pyripyropene衍生物的方法及其生产中间体
WO2009081851A1 (ja) 2007-12-21 2009-07-02 Meiji Seika Kaisha, Ltd. 新規浸透移行性殺虫剤
CA2710791A1 (en) * 2007-12-25 2009-07-02 The Kitasato Institute Pyripyropene derivatives having an acat2-inhibiting activity
NZ590795A (en) 2008-07-24 2012-11-30 Meiji Seika Pharma Co Ltd Pyripyropene a biosynthetic gene
NZ596159A (en) 2009-05-13 2014-03-28 Meiji Seika Pharma Co Ltd Process for producing pyripyropene derivatives
PL2530149T3 (pl) 2010-01-26 2018-04-30 Meiji Seika Pharma Co., Ltd. Struktura kwasu nukleinowego zawierająca klaster genów biosyntezy pirypiropenu i gen markerowy
KR20120127617A (ko) 2010-01-26 2012-11-22 메이지 세이카 파루마 가부시키가이샤 효소 공법에 의한 피리피로펜 유도체의 제조 방법
CN104017839B (zh) 2010-01-26 2017-01-18 明治制果药业株式会社 生产啶南平的方法
UA111151C2 (uk) 2010-03-01 2016-04-11 Мейдзі Сейка Фарма Ко., Лтд. Спосіб одержання похідних пірипіропену
WO2011148886A1 (ja) * 2010-05-24 2011-12-01 Meiji Seikaファルマ株式会社 有害生物防除剤
AU2011303970B2 (en) 2010-09-14 2015-08-13 Basf Se Composition containing a pyripyropene insecticide and an adjuvant
WO2012035010A1 (en) 2010-09-14 2012-03-22 Basf Se Composition containing a pyripyropene insecticide and a base
WO2013135604A1 (en) 2012-03-12 2013-09-19 Basf Se Liquid concentrate formulation containing a pyripyropene insecticide i
WO2013135606A1 (en) 2012-03-12 2013-09-19 Basf Se Method for producing an aqueous suspension concentrate formulation of a pyripyropene insecticide
CN104185421B (zh) 2012-03-12 2016-06-01 巴斯夫欧洲公司 含有啶南平杀虫剂的液体浓缩物配制剂ii
CN102936252B (zh) * 2012-10-22 2015-03-04 中山大学 一类二倍半萜类化合物及其制备方法与应用
MX2015013807A (es) * 2013-03-28 2016-06-02 Basf Se Produccion de piripiropenos a partir de biomasa seca.
CN103910746B (zh) * 2014-02-28 2016-08-03 中山大学 一类海洋真菌来源的Berkeleyones化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US5250935A (en) * 1990-09-24 1993-10-05 Snap-On Tools Corporation Waveform peak capture circuit for digital engine analyzer
US5151365A (en) * 1991-03-18 1992-09-29 Merck & Co., Inc. Culture of Asperigillus versicolor and mutants thereof
JP2993767B2 (ja) * 1991-06-06 1999-12-27 社団法人北里研究所 Fo−1289a物質およびその製造法

Also Published As

Publication number Publication date
KR100323572B1 (ko) 2002-09-04
HU9402127D0 (en) 1994-09-28
JP3233476B2 (ja) 2001-11-26
NO942634L (no) 1995-04-21
EP0667914B1 (de) 1998-07-22
KR950701976A (ko) 1995-05-17
FI103670B (fi) 1999-08-13
DK0667914T3 (da) 1998-11-02
FI103670B1 (fi) 1999-08-13
US5807721A (en) 1998-09-15
FI943383A0 (fi) 1994-07-15
DE69319920T2 (de) 1998-12-10
ATE168722T1 (de) 1998-08-15
FI943383A (fi) 1994-08-31
JPH06184158A (ja) 1994-07-05
HU218015B (hu) 2000-05-28
AU664437B2 (en) 1995-11-16
EP0667914A1 (de) 1995-08-23
NO307519B1 (no) 2000-04-17
NO942634D0 (no) 1994-07-13
CA2127878A1 (en) 1994-04-28
HUT69789A (en) 1995-09-28
NZ249975A (en) 1996-06-25
ES2119894T3 (es) 1998-10-16
WO1994009147A1 (en) 1994-04-28
CA2127878C (en) 1997-07-08
AU3767993A (en) 1994-05-09

Similar Documents

Publication Publication Date Title
DE69319920D1 (de) FO-1289 Verbindung und ihre Herstellung.
DE69018529D1 (de) Phospholipase A2-Inhibitor, Mikroorganismen, die diesen Inhibitor erzeugen und mehrere Verfahren zu seiner Herstellung.
KR930006160A (ko) L-트레오닌의 제조방법
KR960700346A (ko) 면역억제제의 제조방법 및 이에 사용되는 신규 미생물(a process for producing immunosuppressives and a novel microbial species to be employed therein)
FI842807A (fi) Foerfarande foer framstaellning av ett an- tibiotikum aad 216 komplex.
DE69730497D1 (de) Antibiotika produzierende mikrobe
KR840004442A (ko) 란카시딘의 개량 제조방법
HU9200744D0 (en) Biotechnological process for the production of s-(+)-2,2-dimethyl cyclopropane-carboxamide
TW255913B (de)
KR890014457A (ko) 신규 아족시 화합물 및 그의 제조방법
ATE113608T1 (de) Antibiotikum.
ATE58142T1 (de) Valiolaminderivate und ihre herstellung.
KR940011638A (ko) 6β, 14α-디히드록시-4-안드로스텐 3, 17-디온 제조방법
GB1452457A (en) Microbiological production of biologically active 8,8-bi-1h- naphthol-2,3-c-pyrans
FR2322923A2 (fr) Procede de fabrication d'alcool a partir de matieres cellulosiques
KR950014299A (ko) 5'-크산틸산을 생산하는 미생물
KR960041370A (ko) 프라바스타틴(Pravastatin) 전구체의 제조방법
KR850004269A (ko) 미생물에 의한 5'-크산틸산의 제조방법
KR940019866A (ko) 미생물 직접 발효에 의한 사이클로덱스트린(Cyclodextrin)의 제조방법
JPS5794288A (en) Aristeromycin-producing bactria
KR960023041A (ko) 고 전이 활성 β- 갈락토시다제를 생산하는 미생물 및 이를 이용한 고 전이 활성 β-갈락토시다제의 제조방법
KR880001823A (ko) 미생물에 의한 5'-구아닐산의 제조방법.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition